This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| H1N1 | 3560 |
| Influenza | 3509 |
| H5N1 | 2735 |
| ⁄ | 2369 |
| HA | 2197 |
| A | 2071 |
| nan | 1094 |
| RSV | 1079 |
| Health | 1049 |
| PCR | 951 |
| RNA | 942 |
| H3N2 | 871 |
| T | 836 |
| IAV | 801 |
| ILI | 773 |
| C | 757 |
| United | 738 |
| Hong | 724 |
| States | 723 |
| China | 701 |
| B | 696 |
| Kong | 681 |
| SARS | 650 |
| • | 543 |
| Table | 543 |
| Fig | 539 |
| Pandemic | 529 |
| oseltamivir | 503 |
| RT | 453 |
| van | 452 |
| H7N9 | 437 |
| US | 422 |
| World | 416 |
| National | 403 |
| Virus | 378 |
| CDC | 365 |
| USA | 356 |
| M2 | 354 |
| Asia | 354 |
| zanamivir | 343 |
| H9N2 | 332 |
| M | 331 |
| een | 329 |
| Disease | 328 |
| Control | 326 |
| Organization | 322 |
| A(H1N1)pdm09 | 320 |
| CD8 | 306 |
| WHO | 303 |
| Europe | 302 |
| NP | 301 |
| A(H1N1 | 301 |
| H5 | 299 |
| COVID-19 | 298 |
| IFN | 295 |
| Research | 292 |
| Prevention | 280 |
| CI | 275 |
| Institute | 274 |
| ICU | 268 |
| New | 266 |
| April | 265 |
| II | 264 |
| Australia | 261 |
| LAIV | 259 |
| Committee | 251 |
| Africa | 247 |
| pH1N1 | 246 |
| Japan | 245 |
| sha | 241 |
| M1 | 241 |
| UK | 239 |
| het | 239 |
| Vaccine | 235 |
| MDCK | 235 |
| H3 | 233 |
| Human | 228 |
| Department | 227 |
| CD4 | 225 |
| HI | 222 |
| influenza | 218 |
| South | 216 |
| mg | 213 |
| parainfluenza | 207 |
| HPAI | 198 |
| CoV-2 | 197 |
| Flu | 196 |
| H1N1pdm | 190 |
| amantadine | 188 |
| December | 188 |
| University | 185 |
| International | 185 |
| Diseases | 184 |
| H2N2 | 180 |
| NS | 180 |
| October | 180 |
| Infectious | 179 |
| SARI | 178 |
| U.S. | 177 |
| California | 177 |
| haemagglutinin | 176 |
| September | 176 |
| Germany | 176 |
| Public | 175 |
| Russia | 175 |
| H1 | 174 |
| East | 173 |
| Canada | 173 |
| Medical | 172 |
| DOI | 172 |
| HIV | 170 |
| May | 169 |
| PB2 | 169 |
| Surveillance | 169 |
| der | 169 |
| July | 168 |
| Centers | 167 |
| Study | 165 |
| Immunization | 165 |
| ARDS | 165 |
| S. | 164 |
| America | 164 |
| Mexico | 161 |
| S | 161 |
| Oseltamivir | 161 |
| HAI | 160 |
| Thailand | 160 |
| N | 159 |
| Hospital | 159 |
| Center | 159 |
| January | 158 |
| Group | 157 |
| Global | 156 |
| TCID | 155 |
| England | 154 |
| TNF | 153 |
| sera | 152 |
| Netherlands | 150 |
| June | 149 |
| November | 147 |
| NAI | 147 |
| ELISA | 147 |
| Brazil | 147 |
| HLA | 145 |
| M2e | 145 |
| Neuraminidase | 144 |
| ARI | 144 |
| C. | 144 |
| System | 143 |
| North | 143 |
| HEF | 143 |
| H7 | 143 |
| West | 142 |
| A(H3N2 | 139 |
| Victoria | 139 |
| PB1-F2 | 138 |
| F | 138 |
| Northern | 137 |
| Vietnam | 136 |
| Evaluation | 136 |
| Effectiveness | 135 |
| France | 134 |
| J | 132 |
| PA | 131 |
| pH | 130 |
| meta | 129 |
| IIV | 129 |
| Figure | 127 |
| CoV | 127 |
| Viral | 126 |
| H7N7 | 126 |
| Safety | 123 |
| K | 123 |
| MSC | 122 |
| IgA | 122 |
| March | 121 |
| Avian | 121 |
| IV | 120 |
| IC | 119 |
| I | 119 |
| H2 | 117 |
| Association | 116 |
| IL-6 | 116 |
| Advisory | 115 |
| A(H5N1 | 115 |
| H9 | 115 |
| Republic | 113 |
| Ministry | 113 |
| D | 113 |
| Care | 113 |
| pandemic | 112 |
| voor | 112 |
| Respiratory | 112 |
| Development | 111 |
| nucleoprotein | 110 |
| PR8 | 110 |
| Efficacy | 110 |
| PIKA | 108 |
| February | 107 |
| European | 107 |
| COPD | 107 |
| M. | 107 |
| vivo | 107 |
| I. | 106 |
| MS | 106 |
| Korea | 106 |
| Hemisphere | 104 |
| te | 103 |
| Vaccines | 103 |
| Seasonal | 103 |
| L. | 103 |
| Cambodia | 103 |
| B. | 103 |
| India | 102 |
| Laboratory | 102 |
| PBS | 101 |
| Viruses | 99 |
| Spain | 99 |
| en | 98 |
| FDA | 98 |
| Beijing | 98 |
| HA1 | 97 |
| Impact | 97 |
| Yamagata | 96 |
| Practices | 95 |
| Clinical | 95 |
| A(H7N9 | 95 |
| Southern | 95 |
| Virology | 94 |
| IFITM3 | 94 |
| Protection | 92 |
| Analysis | 92 |
| August | 92 |
| Swine | 92 |
| VE | 92 |
| el | 92 |
| rimantadine | 91 |
| Staphylococcus | 91 |
| DNA | 91 |
| City | 90 |
| PB1 | 90 |
| Nile | 90 |
| S1 | 90 |
| von | 90 |
| mRNA | 90 |
| aa | 89 |
| Egypt | 89 |
| Hajj | 89 |
| Novel | 88 |
| Medicine | 88 |
| CA | 88 |
| Network | 87 |
| III | 87 |
| G | 86 |
| Review | 86 |
| bij | 85 |
| baloxavir | 85 |
| Society | 84 |
| Moscow | 84 |
| Middle | 84 |
| H. | 84 |
| Centre | 83 |
| EVs | 83 |
| Ebola | 83 |
| Taiwan | 83 |
| USSR | 82 |
| metapneumovirus | 81 |
| del | 81 |
| Russian | 81 |
| IgG | 81 |
| De | 81 |
| CT | 81 |
| Council | 80 |
| zijn | 80 |
| PIV | 80 |
| Information | 79 |
| HA2 | 79 |
| Immunogenicity | 78 |
| H1N1v | 78 |
| Congo | 78 |
| Eurasia | 77 |
| TIV | 77 |
| Italy | 77 |
| TM | 77 |
| virus | 77 |
| Sciences | 76 |
| Rapid | 75 |
| Office | 75 |
| MRC | 75 |
| TLR3 | 75 |
| H | 74 |
| Aedes | 74 |
| Shanghai | 74 |
| ml | 74 |
| General | 74 |
| dat | 73 |
| Union | 73 |
| State | 73 |
| Orthomyxoviridae | 73 |
| MERS | 73 |
| IL-10 | 73 |
| Bunyaviridae | 73 |
| NF | 72 |
| HCWs | 72 |
| R | 72 |
| Science | 72 |
| La | 71 |
| J. | 71 |
| H5N2 | 71 |
| H275Y | 71 |
| American | 71 |
| ACIP | 71 |
| London | 71 |
| Hemagglutinin | 70 |
| Dr. | 70 |
| Protein | 70 |
| Report | 70 |
| VN | 69 |
| Survey | 69 |
| Risk | 69 |
| Ontario | 69 |
| Infection | 69 |
| IVE | 69 |
| Cross | 68 |
| Studies | 68 |
| Use | 68 |
| Vaccination | 68 |
| un | 67 |
| Province | 67 |
| Pathogenesis | 67 |
| NS2 | 67 |
| Molecular | 67 |
| Epidemiology | 67 |
| Siberia | 66 |
| Turkey | 66 |
| Structure | 66 |
| Sea | 66 |
| MVA | 66 |
| Inc. | 66 |
| Central | 66 |
| Fisher | 65 |
| Assessment | 65 |
| Zealand | 65 |
| α | 65 |
| Ethics | 64 |
| Poisson | 64 |
| Respir | 64 |
| WNV | 64 |
| op | 63 |
| Services | 63 |
| HRV | 63 |
| Animal | 63 |
| Administration | 63 |
| kg | 62 |
| Ixodes | 62 |
| Agency | 62 |
| A/ | 62 |
| < | 62 |
| Data | 61 |
| TMPRSS2 | 61 |
| PM | 61 |
| Drug | 61 |
| des | 61 |
| worden | 61 |
| Ò | 61 |
| E. | 60 |
| Crimean | 60 |
| glycyrrhizin | 60 |
| Eastern | 60 |
| NK | 60 |
| War | 59 |
| Qiagen | 59 |
| Mortality | 59 |
| Management | 59 |
| Isolation | 59 |
| Illness | 59 |
| H1N1pdm09 | 59 |
| Wales | 58 |
| Transmission | 58 |
| Southeast | 58 |
| Response | 58 |
| Kingdom | 58 |
| Government | 58 |
| ERK | 58 |
| los | 58 |
| Detection | 57 |
| wordt | 57 |
| Invitrogen | 57 |
| tot | 56 |
| York | 56 |
| TBEV | 56 |
| Singapore | 56 |
| Program | 56 |
| PICU | 56 |
| P. | 56 |
| MISMS | 56 |
| MF59 | 56 |
| Antiwei | 56 |
| lg | 55 |
| D. | 55 |
| Food | 54 |
| Infections | 54 |
| NIAID | 54 |
| BD | 54 |
| Kazakhstan | 54 |
| SNP | 54 |
| Phase | 54 |
| Zanamivir | 54 |
| Working | 54 |
| Poland | 54 |
| Nairovirus | 53 |
| CSF | 53 |
| Community | 53 |
| Adults | 53 |
| RdRp | 53 |
| Smith | 53 |
| WT | 53 |
| α2 | 53 |
| | | 52 |
| es | 52 |
| Universal | 52 |
| Roche | 52 |
| LPS | 52 |
| IBV | 52 |
| H7N3 | 52 |
| A. | 52 |
| Healthcare | 51 |
| Applied | 51 |
| Box | 51 |
| Scientific | 51 |
| SA | 51 |
| para | 51 |
| R. | 50 |
| Cell | 50 |
| Effect | 50 |
| Emergency | 50 |
| N1 | 50 |
| Indonesia | 50 |
| ROS | 50 |
| Service | 50 |
| Volga | 50 |
| inosine | 50 |
| pdmH1N1 | 50 |
| LTZ | 49 |
| CTL | 49 |
| Far | 49 |
| Great | 49 |
| H5N3 | 49 |
| Investigation | 49 |
| pranobex | 49 |
| NEP | 49 |
| Taxonomy | 49 |
| Treatment | 49 |
| den | 49 |
| Plan | 49 |
| Journal | 48 |
| Australian | 48 |
| BEVS | 48 |
| Ixodidae | 48 |
| NI | 48 |
| Syndrome | 48 |
| VLP | 48 |
| aan | 48 |
| MHC | 47 |
| A&B | 47 |
| BMI | 47 |
| Children | 47 |
| Finland | 47 |
| LPAI | 47 |
| Li | 47 |
| deze | 47 |
| Mongolia | 47 |
| SRH | 47 |
| Spanish | 47 |
| V | 47 |
| endosomal | 47 |
| patiënt | 47 |
| Epidemic | 46 |
| Island | 46 |
| HMPV | 46 |
| Krai | 46 |
| Chen | 46 |
| CM2 | 46 |
| MA | 46 |
| LRTI | 46 |
| MDV | 46 |
| MD | 46 |
| SNPs | 46 |
| SPSS | 46 |
| influenzapandemie | 46 |
| mit | 46 |
| niet | 46 |
| rHA | 46 |
| NAT | 45 |
| Coronavirus | 45 |
| Immune | 45 |
| Kenya | 45 |
| MOI | 45 |
| Dis | 45 |
| NIH | 45 |
| Receptor | 45 |
| Regional | 45 |
| SP | 45 |
| γ | 45 |
| pandemie | 45 |
| Antibody | 44 |
| Chikungunya | 44 |
| Fast | 44 |
| Foundation | 44 |
| L | 44 |
| Lee | 44 |
| MRSA | 44 |
| River | 44 |
| eine | 44 |
| LoS | 43 |
| Burden | 43 |
| College | 43 |
| DAS181 | 43 |
| Ghana | 43 |
| Ifitm3 | 43 |
| Het | 43 |
| MEK | 43 |
| durch | 43 |
| RV | 43 |
| Trm | 43 |
| Wang | 43 |
| Western | 43 |
| RBS | 43 |
| Malaysia | 42 |
| AAV | 42 |
| CMV | 42 |
| DMEM | 42 |
| GISRS | 42 |
| Legionella | 42 |
| Life | 42 |
| MP | 42 |
| Host | 42 |
| Mycoplasma | 42 |
| Sigma | 42 |
| Streptococcus | 42 |
| U | 42 |
| hpi | 42 |
| kan | 42 |
| zu | 42 |
| OSV | 42 |
| K. | 41 |
| Appendix | 41 |
| Astrakhan | 41 |
| Caspian | 41 |
| H274Y | 41 |
| Region | 41 |
| Mechanism | 41 |
| Mediterranean | 41 |
| Vero | 41 |
| adamantane | 41 |
| las | 41 |
| SAS | 40 |
| Amantadine | 40 |
| HIV-1 | 40 |
| Nanopore | 40 |
| AIDS | 40 |
| TLR | 40 |
| middelen | 40 |
| pdm09 | 40 |
| Zambia | 40 |
| Norway | 39 |
| BALB | 39 |
| Biosystems | 39 |
| GenBank | 39 |
| Med | 39 |
| Lung | 39 |
| Paulo | 39 |
| RTI | 39 |
| W. | 39 |
| allantoic | 39 |
| influenzavirus | 39 |
| laninamivir | 39 |
| ISKV | 38 |
| ALI | 38 |
| British | 38 |
| Ct | 38 |
| Darby | 38 |
| GMT | 38 |
| Gc | 38 |
| H1N2 | 38 |
| als | 38 |
| Programme | 38 |
| Uukuniemi | 38 |
| door | 38 |
| kappaB | 38 |
| peramivir | 38 |
| una | 38 |
| ± | 38 |
| School | 38 |
| MF59-adjuvanted | 37 |
| Pathology | 37 |
| Pacific | 37 |
| Madin | 37 |
| Academy | 37 |
| IQR | 37 |
| Board | 37 |
| AOM | 37 |
| RAPIDD | 37 |
| Preparedness | 37 |
| Webster | 37 |
| Soviet | 37 |
| URT | 37 |
| antiinfluenza | 37 |
| bei | 37 |
| dan | 37 |
| doc_id | 37 |
| hemagglutinin | 37 |
| rRT | 37 |
| und | 37 |
| Team | 37 |
| DFA | 36 |
| Guillain | 36 |
| Gn | 36 |
| ED | 36 |
| Arboviruses | 36 |
| DC | 36 |
| CNS | 36 |
| Brisbane | 36 |
| Israel | 36 |
| HK | 36 |
| Project | 36 |
| NHS | 36 |
| RVP | 36 |
| S2 | 36 |
| SLPI | 36 |
| Sofia | 36 |
| Statistics | 36 |
| Technologies | 36 |
| om | 36 |
| patiënten | 36 |
| CE | 35 |
| Emergence | 35 |
| El | 35 |
| Dengue | 35 |
| DCs | 35 |
| Critical | 35 |
| Chinese | 35 |
| H6N1 | 35 |
| Biotechnology | 35 |
| Antiviral | 35 |
| Ann | 35 |
| Allergy | 35 |
| Alere | 35 |
| Adenovirus | 35 |
| Genoa | 35 |
| Model | 35 |
| Healthy | 35 |
| Sentinel | 35 |
| John | 35 |
| ® | 35 |
| antivirale | 35 |
| Toll | 35 |
| Subbarao | 35 |
| St. | 35 |
| Texas | 35 |
| San | 35 |
| N2 | 35 |
| ¼ | 35 |
| Melbourne | 35 |
| Luminex | 35 |
| Lake | 35 |
| PIV3 | 34 |
| EV | 34 |
| Federation | 34 |
| G. | 34 |
| GP | 34 |
| HSCT | 34 |
| InfA | 34 |
| Reference | 34 |
| Pasteur | 34 |
| Population | 34 |
| SIVE | 34 |
| SwIV | 34 |
| Time | 34 |
| heterologous | 34 |
| PR | 33 |
| Ae | 33 |
| Argas | 33 |
| District | 33 |
| Genome | 33 |
| Laboratories | 33 |
| Liu | 33 |
| MC | 33 |
| N95 | 33 |
| Oxford | 33 |
| RNP | 33 |
| Q | 33 |
| Sweden | 33 |
| Toronto | 33 |
| Type | 33 |
| Van | 33 |
| X | 33 |
| baculovirus | 33 |
| i | 33 |
| swine | 33 |
| Institutes | 32 |
| Age | 32 |
| Bio | 32 |
| CPE | 32 |
| FluMist | 32 |
| Georgia | 32 |
| Identification | 32 |
| NIC | 32 |
| NS1 | 32 |
| OC43 | 32 |
| Social | 32 |
| Staph | 32 |
| Zika | 32 |
| lymphopenia | 32 |
| Culex | 31 |
| Joint | 31 |
| H6 | 31 |
| H4 | 31 |
| ER | 31 |
| AI | 31 |
| Anopheles | 31 |
| ATP | 31 |
| O. | 31 |
| AA | 31 |
| MOH | 31 |
| Origin | 31 |
| Omsk | 31 |
| ist | 31 |
| pp | 31 |
| nan | 31 |
| multicentre | 31 |
| sind | 31 |
| heterosubtypic | 31 |
| Viren | 31 |
| Set | 31 |
| RH | 31 |
| JEV | 30 |
| AQI | 30 |
| Arizona | 30 |
| Chi | 30 |
| Cochrane | 30 |
| Diagnostics | 30 |
| Duck | 30 |
| Gene | 30 |
| 30 | |
| HHS | 30 |
| Hyalomma | 30 |
| Islands | 30 |
| zal | 30 |
| Nature | 30 |
| ORF | 30 |
| SINV | 30 |
| Summary | 30 |
| Supplementary | 30 |
| Tamiflu | 30 |
| Vectors | 30 |
| att | 30 |
| werden | 30 |
| MN | 30 |
| E | 29 |
| Laidlaw | 29 |
| Hosts | 29 |
| GlaxoSmithKline | 29 |
| EC | 29 |
| Madrid | 29 |
| Bhanja | 29 |
| Assay | 29 |
| Argasidae | 29 |
| Access | 29 |
| 8) | 29 |
| MI | 29 |
| das | 29 |
| Michael | 29 |
| Systems | 29 |
| Organisation | 29 |
| sich | 29 |
| heeft | 29 |
| TAMV | 29 |
| Technology | 29 |
| S3 | 29 |
| Reye | 29 |
| PubMed | 29 |
| Primorsky | 29 |
| ITIS | 28 |
| Peter | 28 |
| Ornithodoros | 28 |
| Microsoft | 28 |
| MMDS | 28 |
| Index | 28 |
| AE | 28 |
| IL-1 | 28 |
| DR | 28 |
| Case | 28 |
| Associated | 28 |
| Primary | 28 |
| Pneumonia | 28 |
| P&I | 28 |
| RNAseq | 28 |
| antisera | 28 |
| RR | 28 |
| zich | 28 |
| sentinel | 28 |
| ein | 28 |
| du | 28 |
| le | 28 |
| Zhang | 28 |
| Unit | 28 |
| UUKV | 28 |
| TYUV | 28 |
| −/− | 28 |
| T. | 28 |
| Britain | 27 |
| Golgi | 27 |
| F. | 27 |
| David | 27 |
| Collins | 27 |
| Catalonia | 27 |
| CCHFV | 27 |
| Bureau | 27 |
| Abstract | 27 |
| Barr | 27 |
| BATV | 27 |
| Asian | 27 |
| Arthropod | 27 |
| Argentina | 27 |
| Air | 27 |
| HPIV | 27 |
| Gordon | 27 |
| Fletcher | 27 |
| IL-2 | 27 |
| SDS | 27 |
| kunnen | 27 |
| Institutional | 27 |
| con | 27 |
| bronchoalveolar | 27 |
| Tahyna | 27 |
| T2DM | 27 |
| Synthesis | 27 |
| TCM | 27 |
| SD | 27 |
| Phlebovirus | 27 |
| PLoS | 27 |
| NP+M1 | 27 |
| McCullers | 27 |
| MENA | 27 |
| Ltd | 27 |
| IL-15 | 26 |
| Meta | 26 |
| Lancet | 26 |
| LRT | 26 |
| NL63 | 26 |
| Inhibition | 26 |
| Induction | 26 |
| IgM | 26 |
| IL-8 | 26 |
| Black | 26 |
| Hantavirus | 26 |
| Gluc | 26 |
| Epstein | 26 |
| Emerging | 26 |
| Diagnostic | 26 |
| CXR | 26 |
| CASV | 26 |
| Atlanta | 26 |
| Panel | 26 |
| Panama | 26 |
| James | 26 |
| Parainfluenza | 26 |
| kB | 26 |
| tijdens | 26 |
| symptomen | 26 |
| rt | 26 |
| qRT | 26 |
| ng | 26 |
| na | 26 |
| monocyte | 26 |
| mogelijk | 26 |
| zur | 26 |
| hepatitis | 26 |
| Phylogenetic | 26 |
| auch | 26 |
| Paul | 26 |
| Philippines | 26 |
| Patient | 26 |
| Ref | 26 |
| Viet | 26 |
| W | 26 |
| Taubenberger | 26 |
| Corporation | 25 |
| G1 | 25 |
| FLU | 25 |
| Dutch | 25 |
| Deze | 25 |
| Death | 25 |
| Database | 25 |
| Cyprus | 25 |
| Creative | 25 |
| Commons | 25 |
| Comparison | 25 |
| Chronic | 25 |
| Chlamydia | 25 |
| Biological | 25 |
| Bei | 25 |
| AS03 | 25 |
| A2 | 25 |
| Guidelines | 25 |
| CYSTUS052 | 25 |
| GSK | 25 |
| Lithuania | 25 |
| V. | 25 |
| MDS | 25 |
| β | 25 |
| tegen | 25 |
| marboxil | 25 |
| carboxylate | 25 |
| auf | 25 |
| association | 25 |
| White | 25 |
| lm | 25 |
| TCR | 25 |
| SIV | 25 |
| Robert | 25 |
| Practice | 25 |
| PPV | 25 |
| NIRV | 25 |
| Software | 25 |
| Maria | 25 |
| Hayden | 24 |
| Glycyrrhizin | 24 |
| HA0 | 24 |
| HAT | 24 |
| HCV | 24 |
| Immunity | 24 |
| Hien | 24 |
| IL | 24 |
| Ivanovsky | 24 |
| GM | 24 |
| Geneva | 24 |
| Ankara | 24 |
| Flavivirus | 24 |
| Comparative | 24 |
| Columbia | 24 |
| Collection | 24 |
| Chicago | 24 |
| CHIKV | 24 |
| NCR | 24 |
| Antibodies | 24 |
| Act | 24 |
| ARD | 24 |
| Matrix | 24 |
| Azerbaijan | 24 |
| Nam | 24 |
| Thomas | 24 |
| PPP | 24 |
| ν | 24 |
| protein | 24 |
| picornavirus | 24 |
| medRxiv | 24 |
| intranasal | 24 |
| huisarts | 24 |
| hMPV | 24 |
| geen | 24 |
| Trends | 24 |
| simplex | 24 |
| Tetra | 24 |
| Reporting | 24 |
| TLR4 | 24 |
| Pediatric | 24 |
| Puerto | 24 |
| Recommendations | 24 |
| Portugal | 24 |
| Sao | 24 |
| Saudi | 24 |
| Scotland | 24 |
| Short | 24 |
| Infektionen | 23 |
| Depression | 23 |
| Illumina | 23 |
| H3N8 | 23 |
| Guangdong | 23 |
| First | 23 |
| Family | 23 |
| Factors | 23 |
| Directigen | 23 |
| Arabia | 23 |
| Copenhagen | 23 |
| Classification | 23 |
| CHIMV | 23 |
| Baloxavir | 23 |
| BM2 | 23 |
| Antigenic | 23 |
| Anatolia | 23 |
| AOR | 23 |
| MSPL | 23 |
| Ltd. | 23 |
| Jong | 23 |
| NIMR | 23 |
| Text | 23 |
| ° | 23 |
| nicht | 23 |
| hebben | 23 |
| grippe | 23 |
| einer | 23 |
| aviaire | 23 |
| anti | 23 |
| URTI | 23 |
| gripe | 23 |
| TRAIL | 23 |
| Sanofi | 23 |
| S4 | 23 |
| Raf | 23 |
| RCT | 23 |
| Pearson | 23 |
| PR/8/34 | 23 |
| PKR | 23 |
| Season | 23 |
| Green | 22 |
| Fund | 22 |
| GCV | 22 |
| GIP | 22 |
| GPs | 22 |
| Generation | 22 |
| ID | 22 |
| H10N8 | 22 |
| H7N2 | 22 |
| Hepatitis | 22 |
| InfB | 22 |
| Federal | 22 |
| Fluor | 22 |
| Alaska | 22 |
| Excellence | 22 |
| EID | 22 |
| Defense | 22 |
| DENF | 22 |
| Census | 22 |
| Binding | 22 |
| Bij | 22 |
| Anas | 22 |
| An | 22 |
| Kul | 22 |
| Activity | 22 |
| AH | 22 |
| Issyk | 22 |
| heterotypic | 22 |
| Leningrad | 22 |
| Yang | 22 |
| ≥65 | 22 |
| Les | 22 |
| serocomplex | 22 |
| rhinorrhea | 22 |
| ook | 22 |
| neuraminidase | 22 |
| mid | 22 |
| mRNAs | 22 |
| chemoprophylaxis | 22 |
| arboviruses | 22 |
| actividad | 22 |
| Z | 22 |
| su | 22 |
| Washington | 22 |
| SGA | 22 |
| Murphy | 22 |
| VII | 22 |
| Nelson | 22 |
| Neu5Ac | 22 |
| PAGE | 22 |
| People | 22 |
| Sakhalin | 22 |
| Single | 22 |
| Strategy | 22 |
| Ukraine | 22 |
| LTZs | 21 |
| IRF3 | 21 |
| Incidence | 21 |
| KHAV | 21 |
| LD | 21 |
| Outbreak | 21 |
| MCP-1 | 21 |
| Nigeria | 21 |
| OHFV | 21 |
| Heterosubtypic | 21 |
| PyroScript | 21 |
| IDO | 21 |
| Conference | 21 |
| HE | 21 |
| HBC | 21 |
| Excel | 21 |
| Epidemiological | 21 |
| Day | 21 |
| Characterization | 21 |
| Chan | 21 |
| COX-2 | 21 |
| Abs | 21 |
| ARN | 21 |
| AIV | 21 |
| Quality | 21 |
| QYBV | 21 |
| Blood | 21 |
| Queensland | 21 |
| Y | 21 |
| Reassortment | 21 |
| oder | 21 |
| mm | 21 |
| kDa | 21 |
| i.n | 21 |
| fármacos | 21 |
| dans | 21 |
| como | 21 |
| cellulaire | 21 |
| Zhejiang | 21 |
| Yuen | 21 |
| herpes | 21 |
| Writing | 21 |
| SAKV | 21 |
| Whitney | 21 |
| Regulations | 21 |
| Reverse | 21 |
| RhoA | 21 |
| S31N | 21 |
| SHIVERS | 21 |
| Supp | 21 |
| Systematic | 21 |
| TBE | 21 |
| Watch | 21 |
| EpiGraph | 20 |
| H13 | 20 |
| Evolution | 20 |
| Experimental | 20 |
| Flaviviridae | 20 |
| GISAID | 20 |
| Glycosylation | 20 |
| Hungary | 20 |
| HEF2 | 20 |
| HFRS | 20 |
| Haemaphysalis | 20 |
| Herrler | 20 |
| High | 20 |
| IRR | 20 |
| Discovery | 20 |
| Eagle | 20 |
| AUC | 20 |
| Czech | 20 |
| Cox | 20 |
| Commission | 20 |
| Century | 20 |
| Centres | 20 |
| CD14 | 20 |
| CAP | 20 |
| Barré | 20 |
| BMC | 20 |
| BHAV | 20 |
| Anti | 20 |
| Americas | 20 |
| Kim | 20 |
| ATCC | 20 |
| A+B | 20 |
| KHURV | 20 |
| IRF7 | 20 |
| Kyrgyzstan | 20 |
| Singapore/97 | 20 |
| São | 20 |
| TND | 20 |
| Viboud | 20 |
| Weekly | 20 |
| ZTV | 20 |
| bocavirus | 20 |
| cDNA | 20 |
| ca | 20 |
| coryza | 20 |
| favipiravir | 20 |
| klinische | 20 |
| les | 20 |
| pandemisch | 20 |
| LDH | 20 |
| − | 20 |
| Syncytial | 20 |
| ϩ | 20 |
| Serologic | 20 |
| Policy | 20 |
| MEM | 20 |
| Mann | 20 |
| MetaMap | 20 |
| NHG | 20 |
| Pharmaceuticals | 20 |
| NY | 20 |
| QuickVue | 20 |
| Red | 20 |
| Reed | 20 |
| Rights | 20 |
| SH | 20 |
| Security | 20 |
| Sendai | 20 |
| Grant | 19 |
| EU | 19 |
| Environmental | 19 |
| Escherichia | 19 |
| Framework | 19 |
| GPSS | 19 |
| ISSS | 19 |
| H16 | 19 |
| HCoV | 19 |
| HPAIV | 19 |
| Haemagglutinin | 19 |
| IFN- | 19 |
| ECDC | 19 |
| Indian | 19 |
| EGCG | 19 |
| Biosciences | 19 |
| DHOV | 19 |
| Consultation | 19 |
| Cold | 19 |
| CSL | 19 |
| CRP | 19 |
| CD55 | 19 |
| CC | 19 |
| Biomedical | 19 |
| Australians | 19 |
| Army | 19 |
| Application | 19 |
| All | 19 |
| Acute | 19 |
| ANOVA | 19 |
| JS | 19 |
| JNK | 19 |
| profylaxe | 19 |
| Le | 19 |
| Tokyo | 19 |
| Lin | 19 |
| à | 19 |
| ty | 19 |
| ou | 19 |
| min | 19 |
| i.m | 19 |
| huésped | 19 |
| disease | 19 |
| contra | 19 |
| Wu | 19 |
| William | 19 |
| UZAV | 19 |
| Tyuleniy | 19 |
| Tunisia | 19 |
| die | 19 |
| Sydney | 19 |
| Publishing | 19 |
| Switzerland | 19 |
| Mechanisms | 19 |
| Okhotsk | 19 |
| Palese | 19 |
| Peiris | 19 |
| Pfeiffer | 19 |
| MID | 19 |
| RBC | 19 |
| Rh | 19 |
| Seattle | 19 |
| Severe | 19 |
| Springer | 19 |
| HCW | 18 |
| Genesis | 18 |
| Genetic | 18 |
| Getah | 18 |
| Gly | 18 |
| H10 | 18 |
| H5N1-induced | 18 |
| ISN | 18 |
| IAR | 18 |
| ICD-10 | 18 |
| Fc | 18 |
| IVIG | 18 |
| Inhibitor | 18 |
| Interaction | 18 |
| Introduction | 18 |
| Fujian | 18 |
| Area | 18 |
| FRI | 18 |
| DENV | 18 |
| Jun | 18 |
| Belshe | 18 |
| Broad | 18 |
| Clin | 18 |
| Clinic | 18 |
| Congress | 18 |
| DM | 18 |
| English | 18 |
| DMSO | 18 |
| Division | 18 |
| Dynamics | 18 |
| EMA | 18 |
| EV71 | 18 |
| Economic | 18 |
| JAK | 18 |
| group | 18 |
| Kit | 18 |
| aglycoristocetin | 18 |
| Tang | 18 |
| Thermo | 18 |
| Trust | 18 |
| VAED | 18 |
| Wright | 18 |
| Year | 18 |
| μg | 18 |
| Stata | 18 |
| por | 18 |
| proteína | 18 |
| tratamiento | 18 |
| ts | 18 |
| uit | 18 |
| MDA5 | 18 |
| Statistical | 18 |
| Yu | 18 |
| Sequencing | 18 |
| P3 | 18 |
| SI | 18 |
| Martin | 18 |
| Matrosovich | 18 |
| Monitoring | 18 |
| NSW | 18 |
| Non | 18 |
| P | 18 |
| Nicholson | 18 |
| Registry | 18 |
| Relenza | 18 |
| Rep | 18 |
| Resistance | 18 |
| SAR | 18 |
| SHCLCI | 18 |
| Guide | 17 |
| IL-12 | 17 |
| Guinea | 17 |
| HKU1 | 17 |
| Haemophilus | 17 |
| Handbook | 17 |
| Hum | 17 |
| ICD | 17 |
| Louis | 17 |
| INKV | 17 |
| ISCOM | 17 |
| Inhibitors | 17 |
| Intranasal | 17 |
| Iran | 17 |
| Ireland | 17 |
| Jersey | 17 |
| Greece | 17 |
| Guidance | 17 |
| Arbor/6/60 | 17 |
| Glycan | 17 |
| Belgium | 17 |
| Aldrich | 17 |
| Methods | 17 |
| Arboviral | 17 |
| Authority | 17 |
| Background | 17 |
| Bacteriology | 17 |
| Baculovirus | 17 |
| Charles | 17 |
| Genetics | 17 |
| Clara | 17 |
| D.I. | 17 |
| DCP | 17 |
| Denmark | 17 |
| Dix | 17 |
| Dunkin | 17 |
| Fort | 17 |
| MAPK | 17 |
| Los | 17 |
| Microtus | 17 |
| Wagner | 17 |
| analysis | 17 |
| andere | 17 |
| antigen | 17 |
| contacten | 17 |
| han | 17 |
| hemagglutinins | 17 |
| novo | 17 |
| ont | 17 |
| par | 17 |
| plasmacytoid | 17 |
| series | 17 |
| siRNA | 17 |
| son | 17 |
| st | 17 |
| zou | 17 |
| À1 | 17 |
| Monto | 17 |
| Wuhan | 17 |
| jaar | 17 |
| Vertebrate | 17 |
| Pp | 17 |
| UMLS | 17 |
| NT | 17 |
| Natural | 17 |
| Nauka | 17 |
| Open | 17 |
| Pol | 17 |
| Powassan | 17 |
| Paper | 17 |
| Prism | 17 |
| SSR | 17 |
| Standard | 17 |
| Strategies | 17 |
| TMPRSS13 | 17 |
| Tecumseh | 17 |
| Tijdens | 17 |
| Gaussia | 16 |
| IKK | 16 |
| GeneXpert | 16 |
| GmbH | 16 |
| GraphPad | 16 |
| HF | 16 |
| House | 16 |
| Huang | 16 |
| Humoral | 16 |
| Mucosal | 16 |
| IP-10 | 16 |
| Immunology | 16 |
| Kaiser | 16 |
| MOF | 16 |
| MRI | 16 |
| Memory | 16 |
| Miller | 16 |
| G9 | 16 |
| GETV | 16 |
| Activation | 16 |
| Form | 16 |
| Flublok | 16 |
| Overview | 16 |
| Adult | 16 |
| BACKGROUND | 16 |
| BALF | 16 |
| BURV | 16 |
| Barre | 16 |
| BinaxNOW | 16 |
| Biotech | 16 |
| Blackwell | 16 |
| C3 | 16 |
| CXCL10 | 16 |
| Canadian | 16 |
| Culture | 16 |
| Cx | 16 |
| Cytotoxic | 16 |
| DAD | 16 |
| Djibouti | 16 |
| Novartis | 16 |
| Dr | 16 |
| POWV | 16 |
| Veterinary | 16 |
| Welfare | 16 |
| XTD | 16 |
| beleid | 16 |
| ces | 16 |
| clarithromycin | 16 |
| cytopenias | 16 |
| da | 16 |
| df | 16 |
| kinderen | 16 |
| molécules | 16 |
| nucleocapsid | 16 |
| p.i | 16 |
| pandemische | 16 |
| s. | 16 |
| type | 16 |
| une | 16 |
| Peninsula | 16 |
| virales | 16 |
| mAbs | 16 |
| Trials | 16 |
| Rhinovirus | 16 |
| Performance | 16 |
| Territory | 16 |
| Pregnancy | 16 |
| ProCT | 16 |
| Prophylaxis | 16 |
| REIPI | 16 |
| RVDSS | 16 |
| Reactive | 16 |
| Protective | 16 |
| Richard | 16 |
| Santa | 16 |
| Section | 16 |
| Senegal | 16 |
| Star | 16 |
| Rhinoviruses | 16 |
| TLR7 | 16 |
| Tables | 16 |
| ICD-9-CM | 15 |
| Khabarovsk | 15 |
| Likelihood | 15 |
| Library | 15 |
| Lamb | 15 |
| LOD | 15 |
| Infektion | 15 |
| Instituto | 15 |
| Immunisation | 15 |
| IRB | 15 |
| Madagascar | 15 |
| Limited | 15 |
| Nrf2 | 15 |
| Mainland | 15 |
| Medicines | 15 |
| Minister | 15 |
| Mutations | 15 |
| NAIs | 15 |
| NIV | 15 |
| NLRP3 | 15 |
| Nuclear | 15 |
| PPAR | 15 |
| PRAMS | 15 |
| Hospitalizations | 15 |
| Humans | 15 |
| CD16 | 15 |
| Ham | 15 |
| H14 | 15 |
| Adamantane | 15 |
| Aerosol | 15 |
| Antigen | 15 |
| Bangkok | 15 |
| Biology | 15 |
| CCHF | 15 |
| Pfizer | 15 |
| CFR | 15 |
| CPV-2 | 15 |
| Cancer | 15 |
| Carolina | 15 |
| Ceratixodes | 15 |
| Chowell | 15 |
| DPO | 15 |
| Democratic | 15 |
| Deutschland | 15 |
| Dhori | 15 |
| Diagnosis | 15 |
| Director | 15 |
| Ecology | 15 |
| Fever | 15 |
| GSH | 15 |
| German | 15 |
| Pan | 15 |
| NZ | 15 |
| Plague | 15 |
| Tween | 15 |
| Uganda | 15 |
| Windows | 15 |
| YK | 15 |
| administration | 15 |
| bescherming | 15 |
| casos | 15 |
| dagen | 15 |
| dit | 15 |
| dl | 15 |
| echter | 15 |
| eerste | 15 |
| fase | 15 |
| fusión | 15 |
| health | 15 |
| key | 15 |
| meer | 15 |
| national | 15 |
| nog | 15 |
| onder | 15 |
| pneumococcus | 15 |
| qPCR | 15 |
| viral | 15 |
| Plain | 15 |
| UP | 15 |
| ␣ | 15 |
| Tran | 15 |
| Serfling | 15 |
| Planning | 15 |
| Products | 15 |
| Raman | 15 |
| Recognition | 15 |
| Refluvac | 15 |
| Res | 15 |
| SISSS | 15 |
| SYBR | 15 |
| Sanger | 15 |
| Sci | 15 |
| S6 | 15 |
| Sialic | 15 |
| Tajikistan | 15 |
| Student | 15 |
| Thomson | 15 |
| Thai | 15 |
| Test | 15 |
| Thoracic | 15 |
| TMB | 15 |
| TK | 15 |
| TGF | 15 |
| TAHV | 15 |
| Total | 15 |
| Level | 14 |
| Glyprot | 14 |
| HEF1 | 14 |
| HIVE | 14 |
| Household | 14 |
| IAE | 14 |
| IL-1b | 14 |
| Industry | 14 |
| Innovation | 14 |
| Institut | 14 |
| Integrated | 14 |
| NLP | 14 |
| Lvov | 14 |
| MG | 14 |
| Mass | 14 |
| Meteorological | 14 |
| Minor | 14 |
| Myodes | 14 |
| N. | 14 |
| NAC | 14 |
| NADPH | 14 |
| NFκB | 14 |
| NJ | 14 |
| Fogarty | 14 |
| Genomic | 14 |
| County | 14 |
| Fas | 14 |
| Chotpitayasunondh | 14 |
| A1 | 14 |
| Agriculture | 14 |
| Americans | 14 |
| Arbidol | 14 |
| Assembly | 14 |
| Austria | 14 |
| Basel | 14 |
| Challenge | 14 |
| Chemical | 14 |
| Chlamydophila | 14 |
| OR | 14 |
| FIA | 14 |
| Connecticut | 14 |
| Dermacentor | 14 |
| Diego | 14 |
| Distemper | 14 |
| ELISPOT | 14 |
| EVOC | 14 |
| Emerg | 14 |
| Entry | 14 |
| Epidemiol | 14 |
| Expert | 14 |
| Na | 14 |
| einem | 14 |
| Ottawa | 14 |
| demostrado | 14 |
| Uzbekistan | 14 |
| WI | 14 |
| WNF | 14 |
| aantal | 14 |
| acyclovir | 14 |
| adamantanes | 14 |
| behandeling | 14 |
| caspase-3 | 14 |
| cepas | 14 |
| cytomegalovirus | 14 |
| ij | 14 |
| Trial | 14 |
| infecties | 14 |
| leiden | 14 |
| multiorgan | 14 |
| n.d | 14 |
| neuraminidaseremmers | 14 |
| nieuw | 14 |
| pDCs | 14 |
| proteínas | 14 |
| zoals | 14 |
| PIDIRAC | 14 |
| Trivalent | 14 |
| l'infection | 14 |
| Treanor | 14 |
| Rico/8/34 | 14 |
| PPE | 14 |
| Travel | 14 |
| PRISMA | 14 |
| Pathogenicity | 14 |
| Pattern | 14 |
| Polymerase | 14 |
| RIDT | 14 |
| Recombinant | 14 |
| ResPlex | 14 |
| Resources | 14 |
| Petersburg | 14 |
| Royal | 14 |
| Transcaucasia | 14 |
| Togaviridae | 14 |
| Russell | 14 |
| Station | 14 |
| Sichuan | 14 |
| Spearman | 14 |
| Seeplex | 14 |
| Second | 14 |
| SPF | 14 |
| SE | 14 |
| ICMJE | 13 |
| Int | 13 |
| Initiative | 13 |
| ISGs | 13 |
| Interferon | 13 |
| IL-1B | 13 |
| IL-17 | 13 |
| HDI | 13 |
| Herfst | 13 |
| HSV | 13 |
| HN | 13 |
| H1n1 | 13 |
| H12 | 13 |
| LEIV | 13 |
| Gibson | 13 |
| Interim | 13 |
| Monte | 13 |
| Labor | 13 |
| Long | 13 |
| Lyme | 13 |
| Madison | 13 |
| Mark | 13 |
| Maryland | 13 |
| McAuley | 13 |
| MedImmune | 13 |
| MoH | 13 |
| Modeling | 13 |
| NC | 13 |
| Nepal | 13 |
| Ninth | 13 |
| Options | 13 |
| Games | 13 |
| Genbank | 13 |
| BRD | 13 |
| GBS | 13 |
| Apodemus | 13 |
| CS-8958 | 13 |
| CL | 13 |
| Bloom | 13 |
| Bavaria | 13 |
| Origanum | 13 |
| BAL | 13 |
| Alphavirus | 13 |
| Full | 13 |
| Airport | 13 |
| Ageing | 13 |
| AP-1 | 13 |
| AEs | 13 |
| ABI | 13 |
| A(H1N1)v | 13 |
| CSTE | 13 |
| Cellular | 13 |
| Ck | 13 |
| Co. | 13 |
| Cohen | 13 |
| Corp. | 13 |
| Coxsackie | 13 |
| Crystal | 13 |
| Delta | 13 |
| Design | 13 |
| Dit | 13 |
| E2 | 13 |
| Estimation | 13 |
| Ethical | 13 |
| FM/47 | 13 |
| FasL | 13 |
| Fildes | 13 |
| Oral | 13 |
| Lows | 13 |
| P2 | 13 |
| avons | 13 |
| maar | 13 |
| kann | 13 |
| infectie | 13 |
| für | 13 |
| ferret | 13 |
| bronchiolitis | 13 |
| arthralgia | 13 |
| Wong | 13 |
| alle | 13 |
| airways | 13 |
| acetylneuraminic | 13 |
| aber | 13 |
| Xu | 13 |
| Wurzer | 13 |
| messeae | 13 |
| nach | 13 |
| personen | 13 |
| preprint | 13 |
| respiratoire | 13 |
| sciIAVs | 13 |
| square | 13 |
| tds | 13 |
| trans | 13 |
| vaccin | 13 |
| virale | 13 |
| volgende | 13 |
| ward | 13 |
| wird | 13 |
| ‡1:40 | 13 |
| −1 | 13 |
| P4 | 13 |
| Wood | 13 |
| nous | 13 |
| Wisconsin | 13 |
| Qalyub | 13 |
| S5 | 13 |
| Rimantadine | 13 |
| Resource | 13 |
| Rad | 13 |
| RV12 | 13 |
| RUKV | 13 |
| QIAamp | 13 |
| SW | 13 |
| Pseudomonas | 13 |
| Promega | 13 |
| Production | 13 |
| Proceedings | 13 |
| Wilcoxon | 13 |
| Press | 13 |
| SHAP | 13 |
| R0 | 13 |
| Togo | 13 |
| Volgograd | 13 |
| Virological | 13 |
| VI | 13 |
| Voor | 13 |
| Times | 13 |
| TMD | 13 |
| TLRs | 13 |
| Stevens | 13 |
| Stephen | 13 |
| Standards | 13 |
| Sri | 13 |
| Slovakia | 13 |
| Simonsen | 13 |
| Seoul | 13 |
| Gilbert | 12 |
| Girard | 12 |
| Glasgow | 12 |
| Eq | 12 |
| Greater | 12 |
| H11 | 12 |
| GCN4 | 12 |
| H5-VHHb | 12 |
| Geiss | 12 |
| Favipiravir | 12 |
| Francisco | 12 |
| Francis | 12 |
| File | 12 |
| Field | 12 |
| Feng | 12 |
| FLUBV | 12 |
| Establishment | 12 |
| HBV | 12 |
| HAU | 12 |
| Kawaoka | 12 |
| Heart | 12 |
| Jackson | 12 |
| Enterovirus | 12 |
| Lanka | 12 |
| Lab | 12 |
| Knowledge | 12 |
| Karron | 12 |
| KOMV | 12 |
| Johnson | 12 |
| Indigenous | 12 |
| IDSA | 12 |
| Ill | 12 |
| IgG2a | 12 |
| IVB | 12 |
| IU | 12 |
| IMCI | 12 |
| IFITM | 12 |
| IFA | 12 |
| Environment | 12 |
| Agenda | 12 |
| Een | 12 |
| Education | 12 |
| CPMP | 12 |
| CIs | 12 |
| CAM | 12 |
| Bunyamwera | 12 |
| Brazilian | 12 |
| Bocavirus | 12 |
| Bayesian | 12 |
| Based | 12 |
| Arctic | 12 |
| Annual | 12 |
| Andrewes | 12 |
| ATPase | 12 |
| ASC | 12 |
| AP | 12 |
| ADV | 12 |
| ACE2 | 12 |
| 3a | 12 |
| Ca | 12 |
| Candidate | 12 |
| Capital | 12 |
| Company | 12 |
| ET | 12 |
| ECMO | 12 |
| DoD | 12 |
| Distribution | 12 |
| Der | 12 |
| DOCX | 12 |
| Core | 12 |
| Communication | 12 |
| Carlo | 12 |
| Cohort | 12 |
| Code | 12 |
| Cocirculation | 12 |
| Cleveland | 12 |
| Circulation | 12 |
| Choi | 12 |
| Carlsbad | 12 |
| M2SR | 12 |
| MAP | 12 |
| MCO | 12 |
| TOSV | 12 |
| celular | 12 |
| bay | 12 |
| Zambon | 12 |
| Wolff | 12 |
| Wilson | 12 |
| Williams | 12 |
| Wellcome | 12 |
| WBC | 12 |
| Virginia | 12 |
| Veit | 12 |
| Valley | 12 |
| Valencia | 12 |
| VIDRL | 12 |
| VA | 12 |
| Utah | 12 |
| U. | 12 |
| Tropical | 12 |
| chez | 12 |
| dem | 12 |
| drie | 12 |
| transcriptomique | 12 |
| ML | 12 |
| ␥ | 12 |
| в | 12 |
| Ϫ | 12 |
| κB | 12 |
| één | 12 |
| × | 12 |
| sobre | 12 |
| europaea | 12 |
| siRNAs | 12 |
| serologic | 12 |
| rgVac1ins | 12 |
| psittaci | 12 |
| moet | 12 |
| mensen | 12 |
| gebruik | 12 |
| TaqMan | 12 |
| enza | 12 |
| TLKV | 12 |
| PPAbs | 12 |
| PMT | 12 |
| PIV-3 | 12 |
| PAR2 | 12 |
| Operational | 12 |
| OHF | 12 |
| Number | 12 |
| Northeast | 12 |
| Netflix | 12 |
| Minnesota | 12 |
| Microbiology | 12 |
| Melero | 12 |
| McIntosh | 12 |
| Maximum | 12 |
| Manual | 12 |
| MPO | 12 |
| MMR | 12 |
| SuperScript | 12 |
| PO | 12 |
| NonSyn | 12 |
| Pakistan | 12 |
| Reid | 12 |
| St | 12 |
| Spring | 12 |
| Sindbis | 12 |
| Shope | 12 |
| Selection | 12 |
| Sa | 12 |
| SHLCI | 12 |
| Ribavirin | 12 |
| Secretary | 12 |
| QBIC | 12 |
| QAIC | 12 |
| Protocol | 12 |
| Pre | 12 |
| Potsdam | 12 |
| QSS | 12 |
| Patients | 12 |
| IL-18 | 11 |
| HPLC | 11 |
| H8 | 11 |
| HAI-05 | 11 |
| HEPA | 11 |
| Helsinki | 11 |
| HTS | 11 |
| HeLa | 11 |
| H4N6 | 11 |
| H5N6 | 11 |
| Force | 11 |
| Gibco | 11 |
| Gezondheidsraad | 11 |
| Gates | 11 |
| GSRV | 11 |
| GHOR | 11 |
| GA | 11 |
| Future | 11 |
| Florida | 11 |
| FluSure | 11 |
| IL-27 | 11 |
| IL-1β | 11 |
| Mini | 11 |
| ISG | 11 |
| Low | 11 |
| Ferrets | 11 |
| Mono | 11 |
| Mix | 11 |
| Method | 11 |
| Meeting | 11 |
| Medicinal | 11 |
| Master | 11 |
| MFI | 11 |
| Lu | 11 |
| Lambert | 11 |
| IX | 11 |
| LT | 11 |
| Koopmans | 11 |
| Kingdon | 11 |
| Kash | 11 |
| Kalmyk | 11 |
| Jiangsu | 11 |
| Jerusalem | 11 |
| JE | 11 |
| Il | 11 |
| Fields | 11 |
| BKNV | 11 |
| Ferguson | 11 |
| Belarus | 11 |
| CCR5 | 11 |
| CAIV | 11 |
| Brydak | 11 |
| Bris/07 | 11 |
| Bordetella | 11 |
| Biosecurity | 11 |
| Biosafety | 11 |
| Bioline | 11 |
| Berlin | 11 |
| Batai | 11 |
| Cases | 11 |
| Bank | 11 |
| BSL-3 | 11 |
| Myc | 11 |
| Astana | 11 |
| Aegean | 11 |
| Accra | 11 |
| ARTSV | 11 |
| AF03-adjuvanted | 11 |
| A(H2N2 | 11 |
| Cary | 11 |
| Chanock | 11 |
| FFP2 | 11 |
| EW | 11 |
| FBS | 11 |
| Estimating | 11 |
| Es | 11 |
| Erreger | 11 |
| Erkrankungen | 11 |
| Eric | 11 |
| Epidemiologic | 11 |
| Endo | 11 |
| Encephalitis | 11 |
| EIP | 11 |
| Chicken | 11 |
| EIA | 11 |
| Dose | 11 |
| Delivery | 11 |
| Declaration | 11 |
| Davis | 11 |
| Cruz | 11 |
| Complex | 11 |
| Commander | 11 |
| Colombia | 11 |
| Morens | 11 |
| Koch | 11 |
| N1-N9 | 11 |
| Taylor | 11 |
| human | 11 |
| groot | 11 |
| geeft | 11 |
| geadviseerd | 11 |
| est | 11 |
| erythromycin | 11 |
| enkele | 11 |
| bis | 11 |
| antiviral | 11 |
| adenoviral | 11 |
| aalge | 11 |
| a2 | 11 |
| Wuxi | 11 |
| Wiley | 11 |
| Wells | 11 |
| Virol | 11 |
| VTM | 11 |
| U0126 | 11 |
| Toscana | 11 |
| Tick | 11 |
| Thogotovirus | 11 |
| hyperimmune | 11 |
| informatie | 11 |
| ingroup | 11 |
| rs12252 | 11 |
| ≥38 | 11 |
| NALT | 11 |
| été | 11 |
| zum | 11 |
| wie | 11 |
| waarin | 11 |
| vi | 11 |
| unión | 11 |
| sont | 11 |
| rgVac1sub | 11 |
| mL | 11 |
| range | 11 |
| proceso | 11 |
| pandemia | 11 |
| ovo | 11 |
| optreden | 11 |
| obliterans | 11 |
| nt | 11 |
| naar | 11 |
| membrana | 11 |
| Therapy | 11 |
| interferon | 11 |
| TBHQ | 11 |
| Origins | 11 |
| RANTES | 11 |
| Preliminary | 11 |
| Poyang | 11 |
| Philadelphia | 11 |
| Peru | 11 |
| Peramivir | 11 |
| Pediatrics | 11 |
| Patienten | 11 |
| PACF | 11 |
| Nucleoprotein | 11 |
| ROC | 11 |
| Novosibirsk | 11 |
| Next | 11 |
| Newcastle | 11 |
| Nederland | 11 |
| Nacional | 11 |
| NYMC | 11 |
| TA | 11 |
| NSD5 | 11 |
| NBER | 11 |
| RMSE | 11 |
| Pandemrix | 11 |
| Randomized | 11 |
| Se | 11 |
| Sun | 11 |
| Stockholm | 11 |
| Stephenson | 11 |
| Stem | 11 |
| Spread | 11 |
| Special | 11 |
| Small | 11 |
| Slovenia | 11 |
| Sera | 11 |
| Southeastern | 11 |
| Susceptibility | 11 |
| ST | 11 |
| SRID | 11 |
| SR | 11 |
| SOKV | 11 |
| S7 | 11 |
| Role | 11 |
| Regulation | 11 |
| Rev | 11 |
| Inc | 10 |
| IRF-7 | 10 |
| IgG1 | 10 |
| IkappaB | 10 |
| Immunother | 10 |
| Jahren | 10 |
| Independent | 10 |
| Innate | 10 |
| Jin | 10 |
| Interventions | 10 |
| IPMiner | 10 |
| Intensive | 10 |
| HRP | 10 |
| ILC2 | 10 |
| I38X | 10 |
| Hygiene | 10 |
| Houston | 10 |
| Hemagglutination | 10 |
| Hazara | 10 |
| Hall | 10 |
| HIV-2 | 10 |
| HPS | 10 |
| HPA | 10 |
| Jordan | 10 |
| HLH-04 | 10 |
| Jonathan | 10 |
| Measurement | 10 |
| Kentucky | 10 |
| Malta | 10 |
| H15 | 10 |
| Mountain | 10 |
| Mitochondrial | 10 |
| Microbiol | 10 |
| Menschen | 10 |
| Media | 10 |
| McNemar | 10 |
| McElhaney | 10 |
| Mayo | 10 |
| Matthew | 10 |
| Mapping | 10 |
| Macaca | 10 |
| Krasnodar | 10 |
| Maassab | 10 |
| Ma | 10 |
| MEDI-493 | 10 |
| Lusaka | 10 |
| Lipatov | 10 |
| Lim | 10 |
| Lau | 10 |
| Larus | 10 |
| LL-37 | 10 |
| LBM | 10 |
| Kruskal | 10 |
| H5N1/97 | 10 |
| BSA | 10 |
| Guan | 10 |
| BioMed | 10 |
| Cells | 10 |
| Caspase | 10 |
| Cambridge | 10 |
| CTLs | 10 |
| CFA | 10 |
| CD151 | 10 |
| C2 | 10 |
| Bulgaria | 10 |
| Brown | 10 |
| Biologicals | 10 |
| Bioethics | 10 |
| Bias | 10 |
| Christmas | 10 |
| Bcl-2 | 10 |
| BUNV | 10 |
| Andrew | 10 |
| Alonso | 10 |
| Alert | 10 |
| Ag | 10 |
| Adjuvant | 10 |
| Action | 10 |
| A/(H5N1 | 10 |
| -80 | 10 |
| NIs | 10 |
| Cepheid | 10 |
| Collaboration | 10 |
| Groups | 10 |
| FP | 10 |
| Graham | 10 |
| Glybera | 10 |
| Garcia | 10 |
| GROG | 10 |
| GI | 10 |
| GAR | 10 |
| G6PD | 10 |
| Frequency | 10 |
| Foster | 10 |
| FluBlØk | 10 |
| FilmArray | 10 |
| FFP1 | 10 |
| Consensus | 10 |
| Evolutionary | 10 |
| España | 10 |
| Elsevier | 10 |
| EDs | 10 |
| EA | 10 |
| E3 | 10 |
| Dulbecco | 10 |
| Coronaviruses | 10 |
| Copan | 10 |
| Controlled | 10 |
| Contribution | 10 |
| NFkB | 10 |
| flagellin | 10 |
| NSs | 10 |
| eosin | 10 |
| leur | 10 |
| können | 10 |
| influenzalike | 10 |
| inflammasome | 10 |
| il | 10 |
| iNO | 10 |
| hyrcanus | 10 |
| hematoxylin | 10 |
| glycopeptide | 10 |
| glareolus | 10 |
| geven | 10 |
| enteroviruses | 10 |
| manifeste | 10 |
| einen | 10 |
| eficacia | 10 |
| control | 10 |
| complicaties | 10 |
| committee | 10 |
| cefuroxime | 10 |
| bestaat | 10 |
| bd | 10 |
| author(s | 10 |
| aus | 10 |
| atra | 10 |
| maanden | 10 |
| miRNA | 10 |
| a2,3 | 10 |
| syndromic | 10 |
| NTS | 10 |
| ≥40 | 10 |
| −80 | 10 |
| δ | 10 |
| þ | 10 |
| Übertragung | 10 |
| wurden | 10 |
| verspreiding | 10 |
| veroorzaakt | 10 |
| twee | 10 |
| tickborne | 10 |
| standaard | 10 |
| mmol | 10 |
| sciences | 10 |
| ribonucleoproteins | 10 |
| red | 10 |
| qui | 10 |
| putus | 10 |
| perforin | 10 |
| pdm | 10 |
| ongeveer | 10 |
| omdat | 10 |
| nur | 10 |
| nth | 10 |
| acetyl | 10 |
| multibasic | 10 |
| Zheng | 10 |
| Phalacrocorax | 10 |
| Romania | 10 |
| Reviews | 10 |
| Rescue | 10 |
| Replication | 10 |
| RFI-641 | 10 |
| Quebec | 10 |
| Quaranfil | 10 |
| Publisher | 10 |
| Provincial | 10 |
| Preparations | 10 |
| Practitioners | 10 |
| Part | 10 |
| SI/06 | 10 |
| PRRs | 10 |
| PI3K | 10 |
| PHE | 10 |
| PAR-2 | 10 |
| Outcomes | 10 |
| Oregon | 10 |
| Olea | 10 |
| Norwegian | 10 |
| Neutrophil | 10 |
| Zhao | 10 |
| NWs | 10 |
| Rosa | 10 |
| Populations | 10 |
| Saison | 10 |
| VK | 10 |
| Young | 10 |
| Worobey | 10 |
| Sambucus | 10 |
| Workers | 10 |
| Work | 10 |
| Winter | 10 |
| Wei | 10 |
| Waltham | 10 |
| Wallis | 10 |
| WWI | 10 |
| WSN | 10 |
| Victorian | 10 |
| Walter | 10 |
| Standaard | 10 |
| Seroprevalence | 10 |
| Triple | 10 |
| Tests | 10 |
| TX | 10 |
| TWAR | 10 |
| T-705 | 10 |
| Synthetic | 10 |
| Series | 10 |
| Shenzhen | 10 |
| Tucumán | 10 |
| Impfstoffe | 9 |
| Imai | 9 |
| LCI | 9 |
| IRAT | 9 |
| Issues | 9 |
| IL-4 | 9 |
| LLC | 9 |
| Kong/97 | 9 |
| KAMV | 9 |
| KHTV | 9 |
| Kong/68 | 9 |
| Krug | 9 |
| IA | 9 |
| IIV3 | 9 |
| Guardian | 9 |
| Hinshaw | 9 |
| Han | 9 |
| Haem | 9 |
| HRSV | 9 |
| HRSA | 9 |
| HPIV3 | 9 |
| HDU | 9 |
| H7N1 | 9 |
| H3N2/ | 9 |
| Guo | 9 |
| Guangzhou | 9 |
| Greenberg | 9 |
| Law | 9 |
| Good | 9 |
| LP | 9 |
| NY/09 | 9 |
| Leone | 9 |
| Muench | 9 |
| GRNV | 9 |
| Naples | 9 |
| Nanoparticle | 9 |
| Nachweis | 9 |
| NaCl | 9 |
| NP147 | 9 |
| NMR | 9 |
| NIPH | 9 |
| NIBRG-23 | 9 |
| ND | 9 |
| NAbs | 9 |
| N9 | 9 |
| Mycobacterium | 9 |
| Mouse | 9 |
| Lepus | 9 |
| Mount | 9 |
| Modelling | 9 |
| Mice | 9 |
| Metapneumovirus | 9 |
| Marmara | 9 |
| Market | 9 |
| Map | 9 |
| Major | 9 |
| MO | 9 |
| MEGA | 9 |
| MDT | 9 |
| Longini | 9 |
| Local | 9 |
| Gary | 9 |
| AG | 9 |
| GG | 9 |
| Anseriformes | 9 |
| CD40 | 9 |
| CD-1 | 9 |
| CCI | 9 |
| C4 | 9 |
| C1 | 9 |
| Business | 9 |
| Buryatia | 9 |
| Burkholderia | 9 |
| Buhnerkempe | 9 |
| Bradford | 9 |
| BIC | 9 |
| Attribution | 9 |
| Approach | 9 |
| Anderson | 9 |
| CFP | 9 |
| Alliance | 9 |
| Akt | 9 |
| African | 9 |
| AM | 9 |
| AIC | 9 |
| ADCC | 9 |
| ACF | 9 |
| AB | 9 |
| A(H5N8 | 9 |
| A(H10N8 | 9 |
| 3C | 9 |
| -3 | 9 |
| News | 9 |
| CES3 | 9 |
| CP | 9 |
| GCBR | 9 |
| Diagnostik | 9 |
| G2 | 9 |
| Fulica | 9 |
| Fouchier | 9 |
| FMDV | 9 |
| F2 | 9 |